A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
O'Neil, B H, Scott, A J, Ma, W W, Cohen, S J, Aisner, D L, Menter, A R, Tejani, M A, Cho, J K, Granfortuna, J, Coveler, L, Olowokure, O O, Baranda, J C, Cusnir, M, Phillip, P, Boles, J, Nazemzadeh, R, Rarick, M, Cohen, D J, Radford, J, Fehrenbacher, L, Bajaj, R, Bathini, V, Fanta, P, Berlin, J, McRee, A J, Maguire, R, Wilhelm, F, Maniar, M, Jimeno, A, Gomes, C L, Messersmith, W A
Published in Annals of oncology (01.09.2015)
Published in Annals of oncology (01.09.2015)
Get full text
Journal Article
Comparative analyses between younger and older patients with pancreatic adenocarcinoma: differences in clinicopathological features, treatment patterns, and outcomes
Salem, M., Kadakia, K., Trufan, S., Hwang, J., Nazemzadeh, R., Jagosky, M., Worrilow, W., Coley, H., Al Hallak, M., Gower, N., Philip, P., O’Reilly, E.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
O'Neil, B.H., Scott, A.J., Ma, W.W., Cohen, S.J., Aisner, D.L., Menter, A.R., Tejani, M.A., Cho, J.K., Granfortuna, J., Coveler, A.L., Olowokure, O.O., Baranda, J.C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D.J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A.J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C.L., Messersmith, W.A.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
Observations From Early Adoption of Radium 223 (Ra-223) in Heavily Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
McHaffie, D.R, Sharp, H.J, Symanowski, J, Crimaldi, A.J, Mahoney, J, Burgess, E.F, Nazemzadeh, R, Haake, M.R
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Get full text
Journal Article
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
O'Neil, B.H., Scott, A.J., Ma, W.W., Cohen, S.J., Leichman, L., Aisner, D.L., Menter, A.R., Tejani, M.A., Cho, J.K., Granfortuna, J., Coveler, L., Olowokure, O.O., Baranda, J.C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D.J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A.J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C.L., Messersmith, W.A.
Published in Annals of oncology (01.12.2015)
Published in Annals of oncology (01.12.2015)
Get full text
Journal Article
Outcomes and Quality of Care for Anal Cancer Patients Treated With IMRT in a Large Multisite Cancer Center
Moeller, B.J, Heinzerling, J.H, McHaffie, D.R, Sharp, H.J, Prabhu, R.S, Crimaldi, A.J, Haake, M, Lankford, S.P, Bobo, W.E, McCammon, R.J, Thakkar, V.V, Butler, J.M, Gant, D.A, Symanowski, J, Nazemzadeh, R, Hill, J.S, Salo, J.C, Hwang, J.J, Burri, S.H, Fraser, R.W
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Get full text
Journal Article
Optimization of CT slice thickness in 3D-CRT and IMRT planning of low grade glioma
Alirezaei, Z, Amouheidari, A R, Abedi, I, Davanian, F, Shokrani, P, Nazemzadeh, M R
Published in International journal of radiation research (01.04.2021)
Published in International journal of radiation research (01.04.2021)
Get full text
Journal Article
LBA-1 The Phase III Study: Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for locally advanced pancreatic cancer (TIGeR-PaC)
Pishvaian, M., Lopez, C., Zervos, E., Hatoum, H., Berg, D., Ucar, A., Boone, B., Johnson, T., Zureikat, A., Kenneth, M., Chung, K., Gandhi, R., Nazemzadeh, R., Parikh, N., Novelli, P., Kouri, B., Laing, C., Bates, S., Agah, R., Goodman, K.
Published in Annals of oncology (01.06.2023)
Published in Annals of oncology (01.06.2023)
Get full text
Journal Article
P-290Comparative analyses between younger and older patients with pancreatic adenocarcinoma: differences in clinicopathological features, treatment patterns, and outcomes
Salem, M, Kadakia, K, Trufan, S, Hwang, J, Nazemzadeh, R, Jagosky, M, Worrilow, W, Coley, H, Al Hallak, M, Gower, N, Philip, P, O’Reilly, E
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer††This work was previously presented as an abstract at the 2015 Gastrointestinal Cancer Symposium, San Francisco, CA, USA, on 16 January 2015
O'Neil, B.H., Scott, A.J., Ma, W.W., Cohen, S.J., Aisner, D.L., Menter, A.R., Tejani, M.A., Cho, J.K., Granfortuna, J., Coveler, L., Olowokure, O.O., Baranda, J.C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D.J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A.J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C.L., Messersmith, W.A.
Published in Annals of oncology (01.09.2015)
Published in Annals of oncology (01.09.2015)
Get full text
Journal Article